KRAS and pancreatic neoplasm: In addition, P8 decreased ERK activation by 50–80% in MGKRAS003, MGKRAS004, and MGKRAS005, indicating that C14 and P8 significantly inhibit KRas-dependent signaling pathways in primary pancreatic cancer cell cultures.